Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Harmony Biosciences Holdings, Inc. (HRMY)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
4 days ago | Benzinga
5 days ago | Pulse2
5 days ago | GlobeNewsWire
6 days ago | PRNewsWire
2 weeks ago | PRNewsWire
2 weeks ago | PRNewsWire
a month ago | PRNewsWire
2 months ago | PRNewsWire
2 months ago | PRNewsWire
About:
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.